These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33832961)

  • 21. Acute splenic sequestration crisis in children with sickle cell disease.
    Al-Hawsawi ZM; Ismail GA
    Saudi Med J; 2001 Dec; 22(12):1076-9. PubMed ID: 11802180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence-based management of sickle cell disease in the emergency department.
    Glassberg J
    Emerg Med Pract; 2011 Aug; 13(8):1-20; quiz 20. PubMed ID: 22164362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving Quality of Care for Sickle Cell Patients in the Pediatric Emergency Department.
    Lin SM; Strouse JJ; Whiteman LN; Anders J; Stewart RW
    Pediatr Emerg Care; 2016 Jan; 32(1):14-6. PubMed ID: 25834959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The utility of screening laboratory studies in pediatric patients with sickle cell pain episodes.
    Chapman JI; El-Shammaa EN; Bonsu BK
    Am J Emerg Med; 2004 Jul; 22(4):258-63. PubMed ID: 15258863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Splenectomy versus conservative management for acute sequestration crises in people with sickle cell disease.
    Owusu-Ofori S; Riddington C
    Cochrane Database Syst Rev; 2002; (4):CD003425. PubMed ID: 12519596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Splenectomy versus conservative management for acute sequestration crises in people with sickle cell disease.
    Owusu-Ofori S; Remmington T
    Cochrane Database Syst Rev; 2015 Sep; (9):CD003425. PubMed ID: 26344060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Splenectomy versus conservative management for acute sequestration crises in people with sickle cell disease.
    Owusu-Ofori S; Hirst C
    Cochrane Database Syst Rev; 2013 May; (5):CD003425. PubMed ID: 23728644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: a randomized controlled trial.
    Lubega FA; DeSilva MS; Munube D; Nkwine R; Tumukunde J; Agaba PK; Nabukenya MT; Bulamba F; Luggya TS
    Scand J Pain; 2018 Jan; 18(1):19-27. PubMed ID: 29794277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute splenic sequestration crises in adults with sickle cell disease.
    Solanki DL; Kletter GG; Castro O
    Am J Med; 1986 May; 80(5):985-90. PubMed ID: 3706382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Interrupted Time Series Analysis of the Dissemination of a Sickle Cell Vaso-Occlusive Episode Treatment Algorithm and a Case Management Referral Form for Individuals With Sickle Cell Disease in the Emergency Department.
    Bulgin D; Bonnabeau E; Alexander A; Frederick E; Rains G; Shah N; Young M; Tanabe P
    J Emerg Nurs; 2021 Jan; 47(1):40-49.e1. PubMed ID: 32826064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Types of crises in sickle cell disease patients presenting at the haematology day care unit (HDCU), University College Hospital (UCH), Ibadan.
    Olabode JO; Shokunbi WA
    West Afr J Med; 2006; 25(4):284-8. PubMed ID: 17402517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergency Department Sickle Cell Assessment of Needs and Strengths (ED-SCANS), a focus group and decision support tool development project.
    Tanabe P; Reddin C; Thornton VL; Todd KH; Wun T; Lyons JS
    Acad Emerg Med; 2010 Aug; 17(8):848-58. PubMed ID: 20670322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
    Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
    JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subdissociative intranasal ketamine plus standard pain therapy versus standard pain therapy in the treatment of paediatric sickle cell disease vaso-occlusive crises in resource-limited settings: study protocol for a randomised controlled trial.
    Young JR; Sawe HR; Mfinanga JA; Nshom E; Helm E; Moore CG; Runyon MS; Reynolds SL
    BMJ Open; 2017 Jul; 7(7):e017190. PubMed ID: 28698351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hospitalisations for sickle-cell disease in an Australian paediatric population.
    Teoh Y; Greenway A; Savoia H; Monagle P; Roy J; Barnes C
    J Paediatr Child Health; 2013 Jan; 49(1):68-71. PubMed ID: 23198729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First report of successful stem cell transplantation in a patient with sickle cell hemoglobin D disease.
    Hamidieh AA; Jalili M; Khojasteh O; Ghavamzadeh A
    J Pediatr Hematol Oncol; 2010 Jul; 32(5):397-9. PubMed ID: 20502357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benchmarking pain outcomes for children with sickle cell disease hospitalized in a tertiary referral pediatric hospital.
    Vijenthira A; Stinson J; Friedman J; Palozzi L; Taddio A; Scolnik D; Victor C; Kirby-Allen M; Campbell F
    Pain Res Manag; 2012; 17(4):291-6. PubMed ID: 22891195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Saudi family with sickle cell disease presented with acute crises and COVID-19 infection.
    Al-Hebshi A; Zolaly M; Alshengeti A; Al Qurainees G; Yamani S; Hamdan N; Alwasaidi T
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28547. PubMed ID: 32648991
    [No Abstract]   [Full Text] [Related]  

  • 39. Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease.
    Ataga KI; Kutlar A; Kanter J; Liles D; Cancado R; Friedrisch J; Guthrie TH; Knight-Madden J; Alvarez OA; Gordeuk VR; Gualandro S; Colella MP; Smith WR; Rollins SA; Stocker JW; Rother RP
    N Engl J Med; 2017 Feb; 376(5):429-439. PubMed ID: 27959701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
    Krishnamoorthy P; Alyaarubi S; Abish S; Gale M; Albuquerque P; Jabado N
    Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.